HomeTrading IdeasAmazon, Defense Stocks in...

Amazon, Defense Stocks in Spotlight Amid Trade and Consumer Uncertainty

US stocks are modestly higher as investors weigh up the latest announcements from President Trump and watch for further trade developments.

President Trump announced plans to impose 50% tariffs on imports, sending prices sharply higher. US copper prices shot 13% higher, closing at a record high of $5.69 per tonne on Tuesday, following the threat.

Trup also talked of tariffs on semiconductors and pharmaceuticals. These latest developments follow Trump’s sending of letters to 14 countries yesterday, with an additional seven countries set to receive letters today. The deadline has been set for August 1.

Stocks on Wall Street were little changed on Tuesday as the market appears to be in a wait-and-see mood. Last week, U.S. stocks reached a record high.

Attention is also turning to the due later today. The minutes relate to the previous meeting where the Fed left rates unchanged but warned of the expected inflationary impact of tariffs. A hawkish-sounding Fed could pull stocks lower and lift the USD.

Corporate News

Amazon (NASDAQ:) is in focus as its 4-day Prime Day continues. Investors will watch for details on the consumer.

Defence stocks are expected to rise after strong gains in Europe.

US banks will kick off earnings season next week, following a rise to record highs in Q2.

Dow Jones Forecast – Technical Analysis

The Dow Jones has extended its recovery to 44,800, just shy of its 45,000 record high reached in January. The RSI is tipping into overbought territory, so some consolidation could be on the cards. Buyers will look to extend the bullish run above 45,0000 to fresh record highs. Meanwhile, immediate support is at 44,500. Below here, 44,000 could offer some support. It would take a drop below 42,800 to negate the near-term bull trend.

FX Markets – USD Rises, EUR/USD Falls

The USD is rising mostly as it continues to recover from its 3.5-year low, despite recent trade tariff announcements. Attention will be on the FOMC meeting minutes due to be released later.

The is falling as the market awaits further news on EU-US trade talks. Trump has suggested that talks are going well and that he expects an announcement on trade with the EU in the coming days.

is unchanged amid a quiet day on the UK economic calendar. The price has eased back from its 3.5-year high reached at the end of last month amid concerns over the outlook for public finances. Expectations are that the government may hike taxes, which are typically deflationary, as it needs to plug a budget deficit.

Oil Hovers Around a 2-Week High

Oil prices are holding steady on Wednesday, hovering around a two-week high reached in the previous session, as markets await clarity on US tariffs and after rising crude inventories in the US.

Figures from the showed that US inventories gained 7.1 million barrels in the week ending July 4th, despite estimates of a 2.8 million barrel draw. Typically, this would have a bearish impact on the price, especially when OPEC+ is also increasing output. EIA inventory data is due shortly.

Chinese inflation data turned positive in June for the first time since January. China is the world’s largest importer of oil.

Furthermore, a peak driving season in the US could help support demand. There are also signs in the market that investors are less worried about the impact of Trump’s trade tariffs, on expectations that he is open to negotiation.

Original Post

Most Popular

More from Author

What To Expect From Johnson & Johnson’s Q2 Earnings – Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson JNJ is set to release its second-quarter earnings...

Why Is Kazia Stock Soaring Today – Kazia Therapeutics (NASDAQ:KZIA)

Kazia Therapeutics KZIA on Wednesday reported preliminary results from the first...

What To Expect From Eli Lilly’s Q2 Earnings – Eli Lilly (NYSE:LLY)

Eli Lilly and Co. LLY is set to release its second-quarter...

Read Now

Massive 69.4% Surge for IGC Pharma in After-Hours Trading: Here’s Why – IGC Pharma (AMEX:IGC)

IGC Pharma Inc IGC witnessed a surge of 69.40%  in its stock value during after-hours trading on Wednesday.What Happened: The stock of IGC Pharma, a company involved in the development of cannabinoid-based therapies for Alzheimer‘s disease, rose by 69.40% to $0.62. This surge followed the closing price...

What To Expect From Johnson & Johnson’s Q2 Earnings – Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson JNJ is set to release its second-quarter earnings on Wednesday, July 16. According to Benzinga Pro data, analysts estimate adjusted earnings of $2.68 per share and sales of $22.85 billion.While overall estimates for 2025 and beyond show only slight increases, investor attention is expected...

Why Is Kazia Stock Soaring Today – Kazia Therapeutics (NASDAQ:KZIA)

Kazia Therapeutics KZIA on Wednesday reported preliminary results from the first patient in its Phase 1b trial evaluating a combination regimen of Paxalisib, Merck & Co Inc’s MRK Keytruda (pembrolizumab), and standard chemotherapy after completing Cycle 1 (21 days) of dosing.The patient, a 61-year-old woman with metastatic...

What To Expect From Eli Lilly’s Q2 Earnings – Eli Lilly (NYSE:LLY)

Eli Lilly and Co. LLY is set to release its second-quarter earnings on August 7. According to Benzinga Pro data, analysts are anticipating adjusted earnings of $5.56 per share and sales of $14.4 billion.Expectations are slightly higher for the quarter, primarily driven by the strong performance of its obesity...

Rhythm Pharma’s Oral Drug For Rare Obesity Shows Promise – Rhythm Pharmaceuticals (NASDAQ:RYTM)

Rhythm Pharmaceuticals, Inc. RYTM on Wednesday released topline results from its Phase 2 trial evaluating bivamelagon (formerly LB54640), an investigational oral melanocortin-4 receptor (MC4R) agonist, in patients with acquired hypothalamic obesity.Hypothalamic obesity is a rare type of obesity resulting from damage to the hypothalamus, a brain region...

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer as Trump announced yet another delay in tariff deadlines – From the approaching July 9th to August 1st, apparently the final warning. The session began with the leading to the upside, followed by general mean-reversion all...

Gilead’s Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million – Gilead Sciences (NASDAQ:GILD)

Gilead Sciences, Inc. GILD on Wednesday announced a strategic partnership agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to supply lenacapavir — Gilead’s twice-yearly injectable HIV-1 capsid inhibitor — for the prevention of HIV as pre-exposure prophylaxis (PrEP).Through the agreement, Gilead will supply enough...

Markets Today: RBNZ Rate Hold, Copper Volatility, DAX Moves Toward Fresh Highs

Chinese stocks are set to hit their highest level in three years as investors hope for new steps to fight deflation and boost the economy. Meanwhile, dropped in London after President Donald Trump issued a new tariff warning.Asian Market WrapThe Shanghai Stock Exchange Composite Index rose...

FDA Approves New Dosing Schedule For Eli Lilly’s Kisunla In Alzheimer’s Treatment – Eli Lilly (NYSE:LLY)

The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s LLY Kisunla (donanemab-azbt) once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD). The FDA approved the drug in July 2024.In the TRAILBLAZER-ALZ 6...

H2 2025: Room for Optimism, Risk for Complacency

Reasons To Be Fearful, Reasons To Be Cheerful It was an eventful first half of the year, to say the least... In January, the rise of DeepSeek was a wake-up call for the world, demonstrating that China is a major competitor to the US in AI and technology. The...

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug – Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA)

Merck & Co. Inc. MRK agreed on Wednesday to acquire Verona Pharma plc VRNA for $107 per American Depository Share (ADS) for a total transaction value of approximately $10 billion. Each ADS represents eight ordinary shares of Verona Pharma.Through the acquisition of this respiratory disease-focused company, Merck...

The Energy Report: Demand Exceeding Supply

It’s the oldest story in the book. Prices go up when demand exceeds supply, not only in oil and products but in wholesale power, driving up electricity costs. The Energy Information Administration (EIA) in its Short-Term Energy Outlook confirmed that we have a global supply deficit. Not only...